Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H pylori eradication: A comparative three-armed randomized clinical trial

World Journal of Gastroenterology

Volumn 12, Issue 30, 2006, Pages 4888-4891

  Mirbagheri, Seyed Amir ^a   Hasibi, Mehrdad ^a   Abouzari, Mehdi ^b   Rashidi, Armin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ampicillin sulbactam; H pylori; Quadruple therapy; Triple therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; SULTAMICILLIN;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHI SQUARE TEST; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DYSPEPSIA; FEMALE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VOMITING;

EID: 33748309036     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i30.4888     Document Type: Article

References (17)

1. Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother 1999; 43: 47-54
2. Wu H, Shi XD, Wang HT, Liu JX. Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin. J Antimicrob Chemother 2000; 46: 121-123
3. Crone J, Granditsch G, Huber WD, Binder C, Innerhofer A, Amann G, Hirschl AM. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr 2003; 36: 368-371
4. McLoughlin RM, O'Morain CA, O'Connor HJ. Eradication of Helicobacter pylori: recent advances in treatment. Fundam Clin Pharmacol 2005; 19: 421-427
5. Horii T, Mase K, Suzuki Y, Kimura T, Ohta M, Maekawa M, Kanno T, Kobayashi M. Antibacterial activities of beta-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori. Helicobacter 2002; 7: 39-45
6. Horii T, Kimura T, Sato-Kawamura K, Nada T, Shibayama K, Ohta M. beta-Lactamase inhibitors have antibacterial activities against Helicobacter pylori. J Infect Chemother 1999; 5: 206-207
7. Crispino P, Iacopini F, Pica R, Consolazio A, Bella A, Cassieri C, Nardi F, Paoluzi P. Beta-lactamase inhibition with clavulanic acid supplementing standard amoxycilhn-based triple therapy does not increase Helicobacter pylori eradication rate. Dig Liver Dis 2005; 37: 826-831
8. Vcev A, Vukovic D, Ivandic A, Vceva A, Dmitrovic B, Kovacic D, Volaric M, Paulini D, Micunovic N, Horvat D, Mihaljevic S. Another therapeutic schedule in eradication of Helicobacter pylori. Acta Med Croatica 1997; 51: 95-99
9. Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotoudemanesh R, Sotoudeh M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arshi S, Majidpour A. Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population. J Gastroenterol Hepatol 2003; 18: 13-17
10. Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 2003; 17: 1137-1143
11. Saberi-Firoozi M, Massarrat S, Zare S, Fattahi M, Javan A, Etaati H, Dehbashi N. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. Am J Gastroenterol 1995; 90: 1419-1423
12. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-433
13. Roghani HS, Massarrat S, Pahlewanzadeh MR, Dashti M. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains. Eur J Gastroenterol Hepatol 1999; 11: 709-712
14. de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995; 30: 401-407
15. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli J Jr. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000; 5: 79-83
16. Siavoshi F, Pourkhajeh AH, Merat S, Asl-Soleimani H, Heydarian E, Khatibian M, Malekzadeh R. Susceptibility of various strains of Helicobacter pylori to selected agents. Arch Iranian Med 2000; 3: 60-63
17. Dore MP, Graham DY, Sepulveda AR, Realdi G, Osato MS. Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins. Antimicrob Agents Chemother 1999; 43: 1803-1804